The theme of this issue of International Journal of Epidemiology is epigenetics. Perhaps, we are rather late as TIME magazine featured an article 'Why your DNA isn't your destiny' in January 2010. 1 The TIME article focused on transgenerational effects of the cycles of famine and plenty affecting Norrbotten, northern Sweden in the 19th century and studied more recently by Lars Byrgen. Byrgen found a marked reduction in longevity of grandchildren whose grandparents had been exposed to abundant food in childhood. Could this be due to inheritance of an epigenetic effect provoked by glut? Or might socio-cultural transmission of environmental factors across generations be a more plausible explanation? Or could it just be a chance finding? Animal experiments may help sort this out. The article cited an agouti mouse (it has a mutant gene that codes for yellow coat, increased body weight and an increased risk of diabetes) experiment that showed that pregnant agouti mice given folic acid and vitamin B12 had offspring with brown coats and normal weight and did not develop diabetes, to illustrate epigenetic effects. One of the mechanisms by which epigenetic changes occur is through methylation of DNA that alters gene expression. Folic acid and vitamin B12 are involved in the methyl donation pathway, leading to methylation of the agouti gene and altering its expression in the offspring. However, such effects are actually within generation (i.e. the fetus and its development into a pup) and do not provide evidence of transgenerational transmission. Undeterred, the TIME article extrapolated from this work to a range of human conditions (autism, memory, longevity and obesity) raising the flag for Lamarckism-the inheritance of acquired characteristics. Popular science writers always find it hard to resist a good story. There is very little evidence in mammals, let alone humans, that epigenetic effects are transmitted through the germ line across subsequent generations in a quantitatively important manner. 2 As with most modern scientific discoveries, epigenetics has its roots in the past. Conrad Waddington used the term 'epigenome' in the 1930s to define the developmental processes by which the genotype gives rise to the phenotype of an organism. In this issue, we reprint his 1943 paper that gives a brief overview of his understanding of the complex processes by which development is controlled by multiple genes, but says nothing about environmental modifiers of gene expression. 3 Jablonka and Lamm 4 highlight how epigenetics now has a more specific meaning-'the study of the mechanisms that lead to persistent developmental changes in gene activities and effects, but do not involve altered DNA base sequences from one generation to the next'. David Haig, 5 also commenting on Waddington, identifies two epigenetic traditions: first Waddington's and second David Nanney's-which distinguish genetic from epigenetic causes of variation in phenotype, and he notes that both traditions are united in 'an interest in how a constant genotype can produce different phenotypes'. Scott Gilbert 6 provides essential context to Waddington's ideas, arising as they did during the Second World War, and as a product of his expertise in both genetics and embryology, resulting in the 'paradigm-changing' idea that genes are responsible for guiding the mechanics of development.
The impact of new biotechnology on our understanding of human genetics and its associations with disease has been dramatic in terms of publications. For example, the Human Genome Epidemiology Network (HuGE) established an electronic archive that enables publication trends to be determined ( Figure 1 ) and archives publications on specific genes and diseases. 7 Haig 5 notes the dramatic rise of papers with the term 'epigenetics' in the title; as a proportion of all genetics papers there has been a 10-fold increase since 1999. He suggests that the lack of an agreed precise definition of 'epigenetics' has enabled scientists from different disciplines to feel they are at the cutting edge of science as their work is 'epigenetic'. The hype will likely continue to fuel the rise in publications, and contribute to difficulties for epidemiologists in keeping up with the exponential growth of knowledge.
To help jobbing epidemiologists to keep up, our editorial by Relton and Davey Smith 8 provides an accessible overview of the field and focuses on what epidemiologists can offer-in particular our methods for causal inference that have been rather unimportant in the design and interpretation of studies of the influence of germline genetic variation. In a methodological paper in this issue on two-stage Mendelian randomization to determine the cause role of epigenetic processes, Relton and Davey Smith provide some very useful background on epigenetic inheritance and methods of measuring DNA methylation, which will help the novice get to grips with the basics of epigenetics. 9 The International Journal of Epidemiology encourages researchers to submit their epigenetic papers for consideration here. But before doing so, authors are strongly advised to read Heijmans and Mill's 10 excellent commentary, 'The seven plagues of epigenetic epidemiology', which catalogues important limitations in the conduct, analysis and interpretation of epigenetic epidemiology studies. As they note, the notion of what we do and how we live our own lives having adverse effects on our children's lives provides goodbut often misleading-media stories.
The scientific contributions on epigenetics reflect the current state of the field. Two of them focus on associations between socio-economic position and epigenetic differences using different methods to assess epigenetic patterns and different study designs. The first study examines the idea that the higher chronic disease prevalence in disadvantaged populations is explained by underlying high levels of chronic inflammation that in turn leads to aberrant DNA methylation.
11 Using a small (n ¼ 666) cross-sectional study from Glasgow, UK, the investigators obtained DNA from 239 participants and carried out a global DNA methylation assay to assess differences in epigenetic patterns between socio-economic groups. Hypomethylation was found in the most socially deprived participants and associations were also found with inflammatory markers. The second study using the 1958 birth cohort included only 40 men drawn from extremes of low and high socio-economic positions in childhood and adulthood.
12 DNA methylation was assessed on adult blood samples using a genome-wide approach examining the methylation status of 20 000 genes and 400 microRNAs. In contrast to the first study, it was possible to examine DNA methylation patterns by functional pathways: extra-cellular signalling, intra-cellular signalling, DNA signalling and metabolism. Stronger associations were found with childhood than adult socio-economic position and different patterns of hyper-and hypomethylation were found for the different functional pathways. What does it all mean? Both sets of investigators make some good suggestions but ultimately much bigger studies are needed with more focused hypotheses that will become feasible as the costs of measuring DNA methylation fall and our understanding of how epigenetic patterns influence development and disease increases. Now, if you think epigenetics is too complicated, take a deep breath in, count to five and turn to Chris Wild's 13 piece 'The exposome: from concept to utility'. He defines it as follows: 'The exposome is composed of every exposure to which an individual is subjected from conception to death.' Wild's idea is to capture the most important pieces of the jigsaw puzzle of the causal mechanisms from genes to disease. Attempting to catalogue the dynamic patterns of exposure, ranging from social to biological processes (and including epigenetic processes), is a daunting but necessary task if we are ever going to be able to make sense of the findings from the current generation of genetic and epigenetic studies.
Finally, for those of us working in Europe please read a rapid response on the International Association of Epidemiology website (http://www .ieaweb.org/). The European Union will replace their Directive on Data Protection with a new General Data Protection Regulation.
14 Consultations on the previous drafts did not result in public health and epidemiology interests gaining sufficient support to ensure our research can easily continue in its present form. For example, studies published in this issue of the Journal would likely require informed consents from study participants for conducting epigenetic tests if not previously requested and cohort participants would be required to give regularly updated consents. We now need some sustained lobbying to revise the current draft.
